Healthcare entity
All 1 tracked stories fall under one category: regulation. Micheál Martin is most often covered alongside European Union, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Micheál Martin, all published on August 16, 2026.
Last mentioned: Aug 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Micheál Martin is most often covered alongside European Union, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Micheál Martin, all published on August 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Micheál Martin. Shared-story counts are live from our verified record — not editorial picks.
HSE Drugs Group recommends against reimbursement
The HSE Drugs Group cites limitations and uncertainties in evidence and price concerns in its non-recommendation for Skyclarys.
Sinn Féin leader urges Taoiseach to intervene
Mary Lou McDonald writes to Micheál Martin seeking full transparency and an urgent meeting with patients ahead of the final HSE decision.
EU approves Skyclarys
Skyclarys receives European Union marketing authorization for Friedreich's ataxia.
A political row has erupted in Ireland after the HSE Drugs Group advised against reimbursing Skyclarys for Friedreich's ataxia, leaving about 200 patients in limbo. Sinn Féin leader Mary Lou McDonald is demanding full transparency and Taoiseach intervention ahead of a final HSE decision later in August.
Micheál Martin is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
